Your browser doesn't support javascript.
loading
Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients.
Gamage, Hasinika K A H; Venturini, Carola; Tetu, Sasha G; Kabir, Masrura; Nayyar, Vineet; Ginn, Andrew N; Roychoudhry, Belinda; Thomas, Lee; Brown, Mitchell; Holmes, Andrew; Partridge, Sally R; Seppelt, Ian; Paulsen, Ian T; Iredell, Jonathan R.
Afiliação
  • Gamage HKAH; Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
  • Venturini C; Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, The University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Tetu SG; Department of Molecular Sciences, Macquarie University, Sydney, NSW, Australia.
  • Kabir M; Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, The University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Nayyar V; Westmead Breast Cancer Institute, Westmead Hospital, Sydney, NSW, Australia.
  • Ginn AN; Intensive Care Unit, Westmead Hospital and The University of Sydney, Sydney, NSW, Australia.
  • Roychoudhry B; Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, The University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Thomas L; Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology, Sydney, NSW, Australia.
  • Brown M; Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, The University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Holmes A; Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, The University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Partridge SR; Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology, Sydney, NSW, Australia.
  • Seppelt I; Charles Perkins Centre, The University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Paulsen IT; Centre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, The University of Sydney and Westmead Hospital, Sydney, NSW, Australia.
  • Iredell JR; Department of Intensive Care Medicine Unit, Nepean Hospital, Sydney University Medical School (Nepean), The University of Sydney, Sydney, NSW, Australia.
Sci Rep ; 11(1): 7252, 2021 03 31.
Article em En | MEDLINE | ID: mdl-33790304
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cefalosporinas / Enterobacteriaceae / Microbiota / Combinação Piperacilina e Tazobactam Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cefalosporinas / Enterobacteriaceae / Microbiota / Combinação Piperacilina e Tazobactam Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido